TLR2变种和Helicobacter pylori:重新审视一个有争议的联系
Duygu Kirkik1,2, Sevgi Demircioglu3, Sevgi Kalkanli Taş1
1Department of Immunology, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkiye.
Upsala journal of medical sciences
|January 8, 2026
概括
这次元分析没有发现Toll-like受体2 (TLR2) 基因变异 (rs3804099,del -196 to -174) 和Helicobacter pylori感染风险之间的联系. 仅靠宿主基因并不能解释对H. pylori感染的不同易感性.
科学领域:
- 免疫遗传学 免疫遗传学
- 微生物学 微生物学
- 人口遗传学 人口遗传学
背景情况:
- 托尔样受体2 (TLR2) 中的多态性被研究为潜在的宿主遗传因素,影响着Helicobacter pylori感染的易感性.
- 关于TLR2基因变异与H. pylori感染之间的关联现有数据仍然没有确定性.
研究的目的:
- 通过元分析,澄清两种常见的TLR2变体rs3804099和del -196 to -174对不同人群的H. pylori感染风险的贡献.
主要方法:
- 在PubMed,Scopus和Web of Science中进行了系统的文献搜索,以查询到2025年1月的病例对照研究.
- 使用随机效应模型计算了具有95%置信区间 (CI) 的聚合赔率比率 (OR).
- 根据PRISMA 2020指南,评估了研究异质性,出版偏差和敏感性.
主要成果:
- 分析了包括4,521名受试者的10项研究.
- 在TLR2 rs3804099或del -196到 -174多态性和H. pylori感染风险之间没有发现任何显著的关联,跨越各种遗传模型 (等位基因,主导基因,衰退基因,同位基因,异位基因).
- 发现了大量的研究间异质性,特别是rs3804099,尽管敏感性分析证实了聚合结果的稳定性.
结论:
- 这一元分析驳斥了TLR2rs3804099或del -196到 -174多态和H. pylori感染之间的一致的遗传关联.
- 由这些TLR2多态体所代表的宿主天生的免疫变异,不仅解释了对H. pylori感染的差异性易感性.
- 未来的研究应该整合细菌毒性因素和宿主免疫遗传特征,以了解H. pylori感染的特定人群风险机制.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
532
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
532
01:30Peptic Ulcer Disease I: Introduction
734
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
734
01:17Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
01:28Peptic Ulcer Disease II: Pathophysiology
1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K